Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

NCT01801111

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 84 locations
View Trial Details
Completed

Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

NCT01836692

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Belfast Health & Social Care NHS Trust - Northern Ireland Cancer Centre Belfast, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Leeds Teaching Hospitals NHS Trust - St James's University Hospital Leeds, United Kingdom
View Trial Details
Completed

A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)

NCT02913443

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • The Ottawa Hospital Cancer Centre; Oncology Ottawa, Ontario, Canada
  • University Health Network; Princess Margaret Hospital; Medical Oncology Dept Toronto, Ontario, Canada
  • Rigshospitalet; Onkologisk Klinik København Ø, Denmark
View Trial Details
Completed

Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer

NCT00363766

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Löwenstein, Germany
View Trial Details
Completed

Sunitinib Non Small Cell Lung Cancer Patients Over 70

NCT00864721

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ocala Oncology Center Ocala, Florida, United States
  • Cancer Centers of Florida, P.A. Ocoee, Florida, United States
  • Minnesota Oncology Hematology, P.A. Minneapolis, Minnesota, United States
  • Cancer Centers of North Carolina Raleigh, North Carolina, United States
View all 13 locations
View Trial Details

Related conditions